USPTO serial 79246041
SOURCEPHLEX
Reviewed by CopyMark Law Group
Reg. 6039116Status 709
- Filing date
- Status date
- Registration date
- Apr 28, 2020
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SOURCEPHLEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark J. Liss
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.Suite 4900180 North Stetson Avenue,Chicago, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advertising services, business management for others; company administration services, namely, business administration services; providing office functions; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business assistance and consultancy in the context of the retailing and wholesaling of medicines; providing of outsourcing services in the field of medicine authorisation, production, sale, safety and monitoring | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific research, laboratory research in the field of pharmaceuticals; industrial analysis and research services in the field of pharmaceuticals; scientific research and development of new products for others in the field of pharmaceuticals; provision of scientific surveys, namely, medical research surveys; development of a web application for inputting and using informative texts for medicines and medical products, in particular user guides, packaging inserts, specialist information, and for providing various documents; database services, namely, electronic storage of data in computer databases; conversion of data or documents from physical to electronic media; research in relation to scientific work; preparation of scientific analysis and assessments; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; medical laboratory services; information technology services for the pharmaceutical and healthcare industries, namely, information technology consulting services; scientific assessment of the efficiency of medicines; services for assessing the efficiency of pharmaceuticals, namely, pharmaceutical product evaluation; scientific analysis and evaluation of product design; scientific analysis and evaluation of product development; quality control testing; materials testing and evaluation; product safety testing; quality control services, namely, testing, analysis and evaluation of the goods of others to determine conformity with certification standards; quality testing of products to determine conformity with certification standards; assistance and consultancy in the nature of pharmaceutical research in the field of medicine safety and monitoring; pharmaceutical drug development consultancy in the field of medicine safety | SECTION 71 - CANCELLED | — |
| 044 | Medical and veterinary medical services; pharmacy advice, namely, provision of pharmaceutical advice for pharmaceutical and medical device companies; providing information relating to the preparation and dispensing of medications | SECTION 71 - CANCELLED | — |
| 045 | Public document filing assistance in the field of medicine authorization, namely, public document filing services pertaining to documents for authorizing medicines featuring documents, reports and files required by regulatory authorities; regulatory compliance consultancy in the field of pharmaceuticals | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PharmaLex GmbH
- Other trademarks owned by PharmaLex GmbH
- Other trademarks owned by PharmaLex GmbH
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named SOURCEPHLEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 13, 2026 | C71T | CANCELLED SECTION 71 | — |
| Apr 28, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 15, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 26, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 6, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 1, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 28, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 22, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 21, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 28, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 22, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 22, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 11, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 11, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 7, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 22, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 22, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 22, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 6, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 16, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 16, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 16, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 16, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 16, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 16, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 17, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 17, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 14, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jun 11, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 28, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 12, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 11, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 30, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 29, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 28, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 26, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 22, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |